The use of psychoactive medications and cognitive function in older adults

Journal of Aging and Health

Volumn 8, Issue 1, 1996, Pages 136-149

  Berg, Stig ^a   Dellasega, Cheryl ^b  

^a Univ College of Health Sciences   (Sweden)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

AGE; AGED; AGING; ARTICLE; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIC TEST; SCORING SYSTEM;

AGED; COGNITION; FEMALE; HUMANS; MALE; PSYCHOLOGICAL TESTS; PSYCHOTROPIC DRUGS;

EID: 0030050135     PISSN: 08982643     EISSN: None     Source Type: Journal    
DOI: 10.1177/089826439600800107     Document Type: Article

References (42)

1. Adelman, A., Daly, M., & Michocki, R. (1990). Alternate drugs. Clinics in Geriatric Medicine, 6, 423-440.
2. Andersson, M. (1989). Elderly patients in nursing homes and in home care. Doctoral disserta- tion University of Göteberg, Sweden.
3. Beardsley, Larson, Burns, Thompson, &Kamerow. (1989). Prescribing psychotropics for elderly nursing home patients. Journal of the American Geriatrics Society, 37(4), 327-330.
4. Beers, M., Avorn, J., Soumerai, S., Everitt, D., Sherman, D., & Salem, S. (1988). Psychoactive medication use in intermediate care facility residents. Journal of the American Medical Association, 260, 3016-3020.
5. Berg, S. (1980). Psychological functioning in 70- and 75-year old people. Acta Psychiatrica Scandinavia, 62(Suppl. 288).
6. Berg, S. (1987). Intelligence and terminal decline. In G. Maddox & E. Busse (Eds.), Aging: The universal experience (pp. 411-416). New York: Springer.
7. Berg, S., Nilsson, L., & Svanborg, A. (1988). Behavioral and clinical aspects-Longitudinal studies. In J. Wattis & I. Hindmarch (Eds.), Psychological assessment of the elderly (pp. 47-60). New York: New York University Press.
8. Breteler, M., Claus, J., Grobbee, D., & Hofman, A. (1994). Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam study. British Medical Journal, 308, 1604-1608.
9. Brookbank, J. (1990). The biology of aging. New York: Harper & Row.
10. Burgio, L., & Hawkins, A. (1991). Behavioral assessment of the effects of psychotropic medication on demented nursing home residents. Behavior Modification, 15(2), 194-212.
11. Burns, B., & Kamerow, D. (1988). Psychotropic drug prescriptions for nursing home residents. Journal of Family Practice, 26, 155-160.
12. Closser, M. (1991). Benzodiazepines and the elderly: A review of potential problems. Journal of Substance Abuse and Treatment, 8(1-2), 35-41.
13. Dellasega, C., Frank, L., & Brown, R. (1994). Factors influencing functional and cognitive competence in older adults. Manuscript submitted for publication.
14. Dellasega, C., & Stricklin, M. (1992). Use of central nervous system medications by elderly home health clients. Manuscript submitted for publication.
15. Elias, M., & Robbins, M. (1991). Where have all the subjects gone? Longitudinal studies of disease and cognitive function. In L. M. Collins & J. L. Horn (Eds.), Best methods for analysis of change: Recent advances, unanswered questions, future directions (pp. 264-272). Washington, DC: American Psychological Association.
16. Fozard, J., Vercruyssen, M., Reynolds, S., Hancock, P., & Quitter, R. (1994). Age differences and changes in reaction time: The Baltimore Longitudinal Study of Aging. Journal of Gerontology, 49(4), 179-189.
17. Garrard, J., Makris, L., Dunham, T., Heston, L., Cooper, S., Ratner, E., Zelterman, D., &Kane, R. (1991). Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. Journal of the American Medical Association, 265, 463-467.
18. German, P., & Burton, L. (1989). Medication and the elderly: Issues of prescription and use. Journal of Aging and Health, 1, 4-34.
19. Greenblatt, D., Harmatz, J., Shapiro, L., Engelherdt, N., Gouthro, T., & Shader, R. (1991). Sensitivity to triazolam in the elderly. New England Journal of Medicine, 324, 1691-1698.
20. Johansson, B., & Berg, S. (1989). The robustness of the terminal decline phenomenon: Longitudinal data from the digit-span memory test. Journal of Gerontology, 44, 184-186.
21. Johansson, B., Zarit, S., & Berg, S. (1992). Changes in cognitive functioning of the oldest old. Journal of Gerontology, 47, P75-P80.
22. Khan, I., & Ghodes, K. (1988). Psychoactive drugs: Improving prescribing practices. Geneva: World Health Organization.
23. Lader, M. (1990). Drug development optimization - Benzodiazepines. Agents and Actions Supplement, 29, 59-69.
24. Lamy, P. (1989). Considerations from pharmacy. The Gerontologist, 26(6), 603-605.
25. Nelson, E., & Dannefer, D. (1992). Aged heterogeneity: Fact or fiction? The fate of diversity in gerontological research. The Gerontologist, 32(1), 17-23.
26. Nikaido, A., Ellinwood, E., Heatherly, D., & Grupta, S. (1990). Age related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology, 100, 90-97.
27. North, D., McAvoy, B., & Powell, A. (1992). Benzodiazepine use in general practice-Is it a problem? New Zealand Medical Journal, 105, 287-289.
28. Olfson, M., & Pincus, H. (1994). Use of benzodiazepines in the community. Archives of International Medicine, 154(11), 1235-1240.
29. Ray, W., Griffin, M., & Malcom, E. (1991). Cyclic antidepressants and the risk of hip fracture. Archives of Internal Medicine, 151, 754-756.
30. Reid, L., Christensen, D., & Stergachis, A. (1990). Medical and psychosocial factors predictive of psychotropic drug use in elderly patients. American Journal of Public Health, 80(11), 1349-1353.
31. Rubin, E. (1986). Psychotropic therapy: Special concerns in the elderly. Hospital Practice, 21, 95-98.
32. Rudorfer, M. (1993). Pharmacokinetics of psychotropic drugs in special populations. Journal of Clinical Psychiatry, 54(Suppl.), 50-56.
33. Ryden, M., Bossenmaier, M., & McLachlan, C. (1991). Aggressive behavior in cognitively impaired nursing home residents. Research in Nursing & Health,14(2), 87-95.
34. Schorr, R., Bauwens, S., & Landefeld, C. (1990). The failure to limit quantities of ben- zodiazepine hypnotic drugs for outpatients: Placing the elderly at risk. American Journal of Medicine, 89(6), 725-732.
35. Schultz, N., Elias, M., Robbins, M., Streeten, D., & Blakeman, N. (1986). A longitudinal comparison of hypertensives and normotensives on the Wechsler Adult Intelligence Scale: Initial findings. Journal of Gerontology, 41, 169-175.
36. Sheahan, S., Hendricks, J., & Coons, S. (1989). Drug misuse among the elderly: A covert problem. Health Values, 13, 22-29.
37. Skoog, I., Lars, N., Landahl, S., &Bertil, S. (1993). Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. International Psychogeriatrics, 5(1), 33-48.
38. Skoog, L., Nilsson, L., Landahl, S., & Steen, B. (1993). Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. International Psychogeriatrics, 5(1), 33-46.
39. Spore, D., Horgas, A., Smyer, M., & Marks, L. (1992). The relationship of antipsychotic drug use, behavior, and diagnoses among nursing home residents. Journal of Aging and Health, ealth, 4, 514-535.
40. Thurstone, L. (1938). Primary mental abilities. Chicago: University of Chicago Press.
41. Weschler,D. (1972).Measurement and appraisal of adult intelligence, Baltimore, MD: Williams and Williams.
42. Yonkers, K., Kando, C., Cole, J., & Blumenthal, S. (1992). Gender differences in pharmacoki- netics and pharmacodynamics of psychotropic medication. American Journal of Psychology, 149(5), 587-595.